Proteolytic activities have been previously proposed to generate new tumor biomarkers, for example in the form of patterns of the serum peptidome amplified by the proteolytic activities of tumor-derived proteases or by the proteolytic degradation of cytokeratin-18 by caspases during apoptosis [27,32]. Here, KRT18 is linked to neoplasm.